MaPGAS Decision Making

NAEnrolling by invitationINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

February 28, 2027

Conditions
Gender DysphoriaGender Dysphoria, AdultGender IncongruenceTransgenderismTranssexualismTransgender PersonsPhalloplasty
Interventions
BEHAVIORAL

MaPGAS Decision Aid

This intervention involves a novel, web-based decision aid tool specifically designed to support transgender and non-binary individuals assigned female at birth in making informed decisions about Metoidioplasty and Phalloplasty Gender Affirming Surgeries (MaPGAS). The tool includes comprehensive information on surgical options, risks, benefits, and medical illustrations to aid in aligning surgical decisions with the individual's personal values and goals.

Trial Locations (2)

84112

University of Utah, Salt Lake City

03755

Dartmouth College, Hanover

All Listed Sponsors
collaborator

University of Utah

OTHER

collaborator

Dartmouth College

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER